Fludarabine, a chemotherapeutic agent for chronic myeloid leukemia, promotes viral replication by targeting signal transducers and activator of transcription 1 (STAT1). Here, STAT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.